FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jacek Jassem

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Magdalena Koczkowska; Janusz Limon; Beata S Lipska; Wojciech Biernat; Joanna Grzeszewska; Jacek Jassem
Primary leiomyosarcoma of the mesentery in two sisters: clinical and molecular characteristics.
Anna Zaczek; Natalia Bednarz-Knoll; Wojciech Biernat; Burkhardt Brandt; Piotr Czapiewski; Aleksandra Markiewicz; Barbara Seroczyńska; Jarosław Skokowski; Anna Supernat; Jolanta Szade; Marzena Wełnicka-Jaśkiewicz; Jacek Jassem
Prognostic value of TOP2A gene amplification and chromosome 17 polysomy in early breast cancer.
Murry W Wynes; Daniel C Christoph; Rafal Dziadziuszko; Jacek Jassem; Krzysztof Konopa; James Ranger-Moore; Bernadette Reyna-Asuncion; Shalini Singh; Adam Sternau; Fred R Hirsch
Thymidylate synthase protein expression by IHC and gene copy number by SISH correlate and show great variability in non-small cell lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jacek Jassem (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Magdalena Koczkowska; Janusz Limon; Beata S Lipska; Wojciech Biernat; Joanna Grzeszewska; Jacek Jassem
Primary leiomyosarcoma of the mesentery in two sisters: clinical and molecular characteristics.
Polish journal of pathology : official journal of the Polish Society of Pathologists 2013;64(1):59-63.
2012: Anna Zaczek; Natalia Bednarz-Knoll; Wojciech Biernat; Burkhardt Brandt; Piotr Czapiewski; Aleksandra Markiewicz; Barbara Seroczyńska; Jarosław Skokowski; Anna Supernat; Jolanta Szade; Marzena Wełnicka-Jaśkiewicz; Jacek Jassem
Prognostic value of TOP2A gene amplification and chromosome 17 polysomy in early breast cancer.
Pathology oncology research : POR 2012;18(4):885-94.
2012: Murry W Wynes; Daniel C Christoph; Rafal Dziadziuszko; Jacek Jassem; Krzysztof Konopa; James Ranger-Moore; Bernadette Reyna-Asuncion; Shalini Singh; Adam Sternau; Fred R Hirsch
Thymidylate synthase protein expression by IHC and gene copy number by SISH correlate and show great variability in non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(6):982-92.
2012: Jacek Jassem
Maintenance chemotherapy in advanced non-small-cell lung cancer.
The lancet oncology 2012;13(3):217-8.
2012: Krystyna Serkies; Rafal Dziadziuszko; Jacek Jassem
Continuous 7-days-a-week external beam irradiation in locally advanced cervical cancer: final results of the Phase I/II study.
International journal of radiation oncology, biology, physics 2012;82(3):1256-61.
2012: Rafal Dziadziuszko; Bernadette Reyna Asuncion; Jacek Jassem; Krzysztof Konopa; James Ranger-Moore; Witold Rzyman; Shalini Singh; Barbara Szostakiewicz; Murry W Wynes; Fred R Hirsch
Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(2):340-7.
2012: Jacek Jassem; Mark Karwal; Ronald Peck; Valerie Poulart; Mario Campone; Luis Fein; Linda Vahdat
Ixabepilone plus capecitabine in advanced breast cancer patients with early relapse after adjuvant anthracyclines and taxanes: a pooled subset analysis of two phase III studies.
Breast (Edinburgh, Scotland) 2012;21(1):89-94.
2012: Anna J Zaczek; Janusz Jaskiewicz; Aleksandra Markiewicz; Wojciech P Olszewski; Tadeusz Pienkowski; Piotr Rhone; Barbara Seroczynska; Jaroslaw Skokowski; Jolanta Szade; Marzena Welnicka-Jaskiewicz; Jacek Jassem
Prognostic significance of TOP2A gene dosage in HER-2-negative breast cancer.
The oncologist 2012;17(10):1246-55.
2012: Renata Duchnowska; Mojgan Haddad; Weidong Huang; Tomasz Jankowski; Michael Bates; Wojciech Biernat; Marc Buyse; Sylwia Debska; Yolanda Lie; Maria Litwiniuk; Agnes Paquet; Fanny Piette; Barbara Radecka; Jeff Sperinde; Barbara Szostakiewicz; Jodi Weidler; Piotr Wysocki; Bogumiła Czartoryska-Arłukowicz; Małgorzata Foszczynska-Kłoda; Jacek Jassem
Correlation between quantitative HER-2 protein expression and risk for brain metastases in HER-2+ advanced breast cancer patients receiving trastuzumab-containing therapy.
The oncologist 2012;17(1):26-35.
2011: Marcin Skrzypski; Rafal Dziadziuszko; Jacek Jassem
MicroRNA in lung cancer diagnostics and treatment.
Mutation research 2011;717(1-2):25-31.
2011: Elżbieta Senkus; Jacek Jassem
Cardiovascular effects of systemic cancer treatment.
Cancer treatment reviews 2011;37(4):300-11.
2011: Marcin Sinacki; Andrzej Badzio; Marzena Wełnicka-Jaśkiewicz; Jan Bogaerts; Martine J Piccart; Patrick Therasse; Ian E Smith; Thomas Hatschek; Jacek Jassem
Pattern of care in locally advanced breast cancer: focus on local therapy.
Breast (Edinburgh, Scotland) 2011;20(2):145-50.
2011: Krystyna Serkies; Ewa Węgrzynowicz; Jacek Jassem
Paclitaxel and cisplatin chemotherapy for ovarian cancer during pregnancy: case report and review of the literature.
Archives of gynecology and obstetrics 2011;283 Suppl 1():97-100.
2010: Andrzej Badzio; Murry W Wynes; Rafal Dziadziuszko; Daniel T Merrick; Marta Pardo; Witold Rzyman; Anna Kowalczyk; Shalini Singh; James Ranger-Moore; Guadalupe Manriquez; Fabien Gaire; Jacek Jassem; Fred R Hirsch
Increased insulin-like growth factor 1 receptor protein expression and gene copy number in small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(12):1905-11.
2010: Anna Zaczek; Aleksandra Markiewicz; Janusz Jaśkiewicz; Tadeusz Pieńkowski; Piotr Rhone; Jacek Jassem; Marzena Wełnicka-Jaśkiewicz
Clinical evaluation of developed PCR-based method with hydrolysis probes for TOP2A copy number evaluation in breast cancer samples.
Clinical biochemistry 2010;43(10-11):891-8.
2010: Rafal Dziadziuszko; Daniel T Merrick; Samir E Witta; Adelita D Mendoza; Barbara Szostakiewicz; Amelia Szymanowska; Witold Rzyman; Katarzyna Dziadziuszko; Jacek Jassem; Paul A Bunn; Marileila Varella-Garcia; Fred R Hirsch
Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(13):2174-80.
2010: Piotr Winczura; Jacek Jassem
Combined treatment with cytoprotective agents and radiotherapy.
Cancer treatment reviews 2010;36(3):268-75.
2010: Krzysztof Konopa; Jacek Jassem
The role of pemetrexed combined with targeted agents for non-small cell lung cancer.
Current drug targets 2010;11(1):2-11.
2009: Jacek Jassem; Christopher Carroll; Sue Ward; Emma Simpson; Daniel Hind
The clinical efficacy of cytotoxic agents in locally advanced or metastatic breast cancer patients pretreated with an anthracycline and a taxane: a systematic review.
European journal of cancer (Oxford, England : 1990) 2009;45(16):2749-58.
2009: Dorota Dworakowska; Ewa Jassem; Jacek Jassem; Andrzej Karmoliński; Mariusz Lapiński; Dariusz Tomaszewski; Witold Rzyman; Kazimierz Jaśkiewicz; Krzysztof Sworczak; Ashley B Grossman
Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2009;66(1):127-33.
2009: Jacek Jassem; Tadeusz Pienkowski; Anna Pluzanska; Svetislav Jelic; Vera Gorbunova; Juris Berzins; Thomas Nagykalnai; Laura Biganzoli; Alessandra Aloe; Ludovic Astier; Stephane Munier
Doxorubicin and paclitaxel versus fluorouracil, doxorubicin and cyclophosphamide as first-line therapy for women with advanced breast cancer: long-term analysis of the previously published trial.
Onkologie 2009;32(8-9):468-72.
2009: Krzysztof Adamowicz; Małgorzata Marczewska; Jacek Jassem
Combining systemic therapies with radiation in breast cancer.
Cancer treatment reviews 2009;35(5):409-16.
2009: Paul Roepman; Jacek Jassem; Egbert F Smit; Thomas Muley; Jacek Niklinski; Tony van de Velde; Anke T Witteveen; Witold Rzyman; Arno Floore; Sjaak Burgers; Giuseppe Giaccone; Michael Meister; Hendrik Dienemann; Marcin Skrzypski; Miroslaw Kozlowski; Wolter J Mooi; nico van zandwijk
An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(1):284-90.
2008: Marcin Skrzypski; Ewa Jassem; Miquel Taron; Jose Javier Sanchez; Pedro Méndez; Witold Rzyman; Grazyna Gulida; Dan Raz; David Jablons; Mariano Provencio; Bartomeu Massuti; Imane Chaib; Laia Perez-Roca; Jacek Jassem; Rafael Rosell
Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(15):4794-9.
2008: Maryla Krajewska; Shinichi Kitada; Jane N Winter; Daina Variakojis; Alan Lichtenstein; Dayong Zhai; Michael Cuddy; Xianshu Huang; Frederic Luciano; Cheryl H Baker; Hoguen Kim; Eunah Shin; Susan Kennedy; Allen H Olson; Andrzej Badzio; Jacek Jassem; Ivo Meinhold-Heerlein; Michael J Duffy; Aaron D Schimmer; Ming Tsao; Ewan Brown; Anne Sawyers; Michael Andreeff; Dan Mercola; Stan Krajewski; John C Reed
Bcl-B expression in human epithelial and nonepithelial malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(10):3011-21.
2008: Jacek Jassem; Rodryg Ramlau; Armando Santoro; Wolfgang Schuette; Assad Chemaissani; Shengyan Hong; Johannes Blatter; Susumu Adachi; Axel Hanauske; Christian Manegold
Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1698-704.
2008: Katarzyna Sosinska-Mielcarek; Katarzyna Sosvinska-Mielcarek; Elzbieta Senkus-Konefka; Jacek Jassem; Julia Kulczycka; Jaroslaw Jendrzejewski; Kazimierz Jaskiewicz
Cardiac involvement at presentation of non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):1010-1.
2008: Jacek Jassem
Intergroup Exemestane Study mature analysis: overall survival data.
Anti-cancer drugs 2008;19 Suppl 1():S3-7.
2008: Jacek Jassem
Exemestane: an alternative treatment option in early breast cancer. Foreward.
Anti-cancer drugs 2008;19 Suppl 1():S1.
2008: Anna Zaczek; Marzena Wełnicka-Jaśkiewicz; Krzysztof Piotr Bielawski; Janusz Jaśkiewicz; Andrzej Badzio; Włodzimierz Olszewski; Piotr Rhone; Jacek Jassem
Gene copy numbers of HER family in breast cancer.
Journal of cancer research and clinical oncology 2008;134(2):271-9.
2008: Elzbieta Senkus-Konefka; Elzbieta Orłowska-Kunikowska; Rafal Dziadziuszko; Jacek Jassem
Exacerbation of diabetes related to exemestane treatment.
Acta oncologica (Stockholm, Sweden) 2008;47(6):1167-9.
2008: Jacek Jassem; Kazimierz Drosik; Rafal Dziadziuszko; Radzislaw Kordek; Jerzy Kozielski; Dariusz Kowalski; Maciej Krzakowski; Jacek Nikliński; Włodzimierz Olszewski; Tadeusz Orłowski; Rodryg Ramlau; Kazimierz Roszkowski-Sliz
[Systemic treatment of non-small cell lung cancer--recommendations based on the results of reliable clinical trials].
Pneumonologia i alergologia polska 2008;76(1):44-52.
2008: E Bednaruk-Młynski; Elzbieta Senkus-Konefka; P Szewczyk; Andrzej Badzio; Jacek Jassem
Parallel-opposed fields versus four fields, and two- versus three-dimensional radiotherapy planning in thin patients with gynecological malignancies.
Neoplasma 2008;55(2):151-7.
2008: Magdalena Ratajska; Izabela Brozek; Elzbieta Senkus-Konefka; Jacek Jassem; Magdalena Stepnowska; Grazia Palomba; Marina Pisano; Milena Casula; Giuseppe Palmieri; Ake Borg; Janusz Limon
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
Oncology reports 2008;19(1):263-8.
2007: Elzbieta Senkus-Konefka; Jacek Jassem
Cardiovascular effects of breast cancer radiotherapy.
Cancer treatment reviews 2007;33(6):578-93.
2007: Jacek Jassem
The role of radiotherapy in lung cancer: where is the evidence?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;83(2):203-13.
2007: Rafael Rosell; Marcin Skrzypski; Ewa Jassem; Miquel Taron; Roberta Bartolucci; Jose Javier Sanchez; Pedro Méndez; Imane Chaib; Laia Perez-Roca; Amelia Szymanowska; Witold Rzyman; Francesco Puma; Grazyna Kobierska-Gulida; Raffaele Farabi; Jacek Jassem
BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.
PloS one 2007;2(11):e1129.
2007: Zygmunt Chodorowski; Jacek Sein Anand; Jacek Jassem; Andrzej Kopacz; Wieslaw Kruszewski; Janusz Emerich; Elzbieta Senkus-Konefka
[Late recurrence of malignant tumours 20 years after diagnosis and treatment].
Przegla̧d lekarski 2007;64(4-5):372-3.
2007: Renata Zaucha; Jan M Zaucha; Jacek Jassem
Resolution of thymoma-related pure red cell aplasia after octreotide treatment.
Acta oncologica (Stockholm, Sweden) 2007;46(6):864-5.
2007: Maciej Krzakowski; Tadeusz Orłowski; Kazimierz Roszkowski; Marian Reinfuss; Włodzimierz Olszewski; Rodryg Ramlau; Dariusz Kowalski; Krzysztof Konopa; Jacek Jassem; Renata Jankowska; Jerzy Kozielski; Marek Z Wojtukiewicz; Kazimierz Drosik; Piotr Koralewski
[Small-cell lung cancer diagnostic and therapeutic recommendations of Polish Lung Cancer Group].
Pneumonologia i alergologia polska 2007;75(1):88-94.
2007: Rafal Dziadziuszko; Anna Siemiatkowska; Janusz Limon; Witold Rzyman; Jacek Jassem; Paul A Bunn; Marileila Varella-Garcia; Fred R Hirsch
Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: a case report.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(1):91-2.
2006: Marzena Wełnicka-Jaśkiewicz; Anna Zaczek; Burkhard Brandt; Krzysztof Piotr Bielawski; Janusz Jaśkiewicz; Krzysztof Konopa; Jacek Jassem
(CA)n microsatellite polymorphism of ERBB-1 in breast cancer.
European journal of cancer (Oxford, England : 1990) 2006;42(12):1698-701.
2006: Witold Rzyman; Ole M Hagen; Rafal Dziadziuszko; Grazyna Kobierska-Gulida; Andrzej Karmolinski; Inger M Lothe; Almira Babovic; Maciej Murawski; Waldemar Paleczka; Tomasz Jastrzebski; Andrzej Kopacz; Jacek Jassem; Piotr Lass; Jan Skokowski
Intraoperative, radio-guided sentinel lymph node mapping in 110 nonsmall cell lung cancer patients.
The Annals of thoracic surgery 2006;82(1):237-42.
2006: Elzbieta Senkus-Konefka; Edmund Naczk; Ilona Borowska; Andrzej Badzio; Jacek Jassem
Changes in lateral dimensions of irradiated volume and their impact on the accuracy of dose delivery during radiotherapy for head and neck cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;79(3):304-9.
2006: Krystyna Serkies; Jacek Jassem; Rafal Dziadziuszko
Chemotherapy with mitomycin c, ifosfamide, and cisplatin for recurrent or persistent cervical cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(3):1152-6.
2006: Ewa Jassem; Krystyna Serkies; Rafal Dziadziuszko; Adrianna Drozdowska; Grazyna Kobierska-Gulida; Jan Skokowski; S Góźdź; A Urbaniak; Jacek Sygut; Jacek Jassem
Prognostic value of S-100 immunostaining in tumour cells of non-small cell lung cancer.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2006;11(3):262-9.
2006: Witold Rzyman; O M Hagen; Rafal Dziadziuszko; Grazyna Kobierska-Gulida; Andrzej Karmolinski; M I Lothe; W Paleczka; Maciej Murawski; Tomasz Jastrzebski; Andrzej Kopacz; Jacek Jassem; Jan Skokowski
Blue-dye intraoperative sentinel lymph node mapping in early non-small cell lung cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2006;32(4):462-5.
2006: Katarzyna Sosińska-Mielcarek; Elzbieta Senkus-Konefka; Kazimierz Jaskiewicz; Radzislaw Kordek; Jacek Jassem
Intraocular malignant teratoid medulloepithelioma in an adult: clinicopathological case report and review of the literature.
Acta ophthalmologica Scandinavica 2006;84(2):259-62.
2006: Elzbieta Senkus-Konefka; Jacek Jassem
Complications of breast-cancer radiotherapy.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2006;18(3):229-35.
2006: Amelia Szymanowska; Ewa Jassem; Rafal Dziadziuszko; Ake Borg; Janusz Limon; Grazyna Kobierska-Gulida; Witold Rzyman; Jacek Jassem
Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Lung cancer (Amsterdam, Netherlands) 2006;52(1):9-14.
2006: Krystyna Serkies; Andrzej Badzio; Jacek Jassem
Clinical relevance of hemoglobin level in cervical cancer patients administered definitive radiotherapy.
Acta oncologica (Stockholm, Sweden) 2006;45(6):695-701.
2006: Katarzyna Schultka; Bartlomiej Ciesielski; Krystyna Serkies; Tomasz Sawicki; Zofia Tarnawska; Jacek Jassem
EPR/alanine dosimetry in LDR brachytherapy--a feasibility study.
Radiation protection dosimetry 2006;120(1-4):171-5.
2005: Marcin Sinacki; Jacek Jassem; Geertjan van Tienhoven
Conservative local treatment versus mastectomy after induction chemotherapy in locally advanced breast cancer: a randomised phase III study (EORTC 10974/22002, LAMANOMA)--why did this study fail?
European journal of cancer (Oxford, England : 1990) 2005;41(18):2787-8.
2005: Ewa Majdak; Jaroslaw Debniak; Tomasz Milczek; Cees J Cornelisse; Peter Devilee; Janusz Emerich; Jacek Jassem; Geertruida H de Bock
Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinoma.
Cancer 2005;104(5):1004-12.
2005: Dorota Dworakowska; Ewa Jassem; Jacek Jassem; A Karmoliński; Rafal Dworakowski; T Wirth; M Gruchała; Andrzej Rynkiewicz; Jan Skokowski; S Yla-Herttuala; K Jaśkiewicz; Eugenia Czestochowska
Clinical significance of apoptotic index in non-small cell lung cancer: correlation with p53, mdm2, pRb and p21WAF1/CIP1 protein expression.
Journal of cancer research and clinical oncology 2005;131(9):617-23.
2005: Dorota Dworakowska; Ewa Jassem; Jacek Jassem; Carsten Boltze; Klaus Hermann Wiedorn; Rafal Dworakowski; Jan Skokowski; Kazimierz Jaśkiewicz; Eugenia Czestochowska
Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC).
Journal of cancer research and clinical oncology 2005;131(7):479-85.
2005: Krystyna Serkies; Jacek Jassem
Chemotherapy in the primary treatment of cervical carcinoma.
Critical reviews in oncology/hematology 2005;54(3):197-208.
2005: Natasha B Leighl; Luis Paz-Ares; Jean-Yves Douillard; Christian Peschel; Andrew Arnold; Alain Depierre; Armando Santoro; Daniel C Betticher; Ulrich Gatzemeier; Jacek Jassem; Jeffrey Crawford; Dongsheng Tu; Andrea Bezjak; Jeff Humphrey; Maurizio Voi; Susan Galbraith; Katherine Hann; Lesley Seymour; Frances A Shepherd
Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2831-9.
2005: Barbara A Jereczek-Fossa; Chiara Casadio; Jacek Jassem; Felipe Luzzatto; Giuseppe Viale; Roberto Bruschini; Fausto Chiesa; Roberto Orecchia
Branchiogenic carcinoma--conceptual or true clinico-pathological entity?
Cancer treatment reviews 2005;31(2):106-14.
2005: Elzbieta Senkus-Konefka; Rafal Dziadziuszko; E Bednaruk-Młyński; A Pliszka; J Kubrak; A Lewandowska; K Małachowski; M Wierzchowski; M Matecka-Nowak; Jacek Jassem
A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC).
British journal of cancer 2005;92(6):1038-45.
2005: Krystyna Serkies; Andrzej Badzio; Jacek Jassem
[The role of radiotherapy in the management of esophageal cancer].
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2005;18(105):332-5.
2005: Luca Calabrese; Barbara A Jereczek-Fossa; Jacek Jassem; Andrea Rocca; Roberto Bruschini; Roberto Orecchia; Fausto Chiesa
Diagnosis and management of neck metastases from an unknown primary.
Acta otorhinolaryngologica Italica : organo ufficiale della Società italiana di otorinolaringologia e chirurgia cervico-facciale 2005;25(1):2-12.
2005: Amelia Szymanowska; Ewa Jassem; Rafal Dziadziuszko; Marcin Skrzypski; Grazyna Kobierska-Gulida; Karolina Holm; Ake Borg; Witold Rzyman; Janusz Limon; Jacek Jassem
[Analysis of prognostic value of TP53 gene mutations in non-small cell lung cancer].
Pneumonologia i alergologia polska 2005;73(3):264-9.
2005: Krystyna Serkies; Ewa Wegrzynowicz; Jacek Jassem
[Adjuncts to surgery in cervical cancer].
Przegla̧d lekarski 2005;62(12):1460-4.
2005: Dorota Dworakowska; Ewa Jassem; Jacek Jassem; Carsten Boltze; Klaus Hermann Wiedorn; Rafal Dworakowski; Jan Skokowski; Kazimierz Jaśkiewicz; Eugenia Czestochowska
Absence of prognostic significance of p21(WAF1/CIP1) protein expression in non-small cell lung cancer.
Acta oncologica (Stockholm, Sweden) 2005;44(1):75-9.
2005: Ewa Majdak; Geertruida H de Bock; Izabela Brozek; Magdalena Perkowska; Karolina Ochman; Jaroslaw Debniak; Tomasz Milczek; Cees J Cornelisse; Jacek Jassem; Janusz Emerich; Janusz Limon; Peter Devilee
Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases - preliminary report.
European journal of cancer (Oxford, England : 1990) 2005;41(1):143-50.
2004: Elzbieta Senkus-Konefka; Marzena Wełnicka-Jaśkiewicz; Janusz Jaśkiewicz; Jacek Jassem
Radiotherapy for breast cancer in patients undergoing breast reconstruction or augmentation.
Cancer treatment reviews 2004;30(8):671-82.
2004: Magdalena Chmara; Agnieszka Wozniak; Karolina Ochman; Grazyna Kobierska; Rafal Dziadziuszko; Katarzyna Sosinska-Mielcarek; Ewa Jassem; Jan Skokowski; Jacek Jassem; Janusz Limon
Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.
Anticancer research 2004;24(6):4259-63.
2004: Krystyna Serkies; Jacek Jassem
Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
International journal of radiation oncology, biology, physics 2004;60(3):814-21.
2004: R Zaucha; K Sosińska-Mielcarek; Jacek Jassem
Long-term survival of a patient with primarily chemo-resistant metastatic breast cancer treated with medroxyprogesterone acetate.
Breast (Edinburgh, Scotland) 2004;13(4):321-4.
2004: Barbara A Jereczek-Fossa; Andrzej Badzio; Jacek Jassem
Time without symptoms and toxicity (TWIST) analysis of adjuvant radiation therapy for endometrial cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;72(2):175-81.
2004: Andrzej Badzio; Krzysztof Kurowski; Hanna Karnicka-Mlodkowska; Jacek Jassem
A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2004;26(1):183-8.
2004: Barbara A Jereczek-Fossa; Daniela Alterio; Jacek Jassem; Bianca Gibelli; Nicoletta Tradati; Roberto Orecchia
Radiotherapy-induced thyroid disorders.
Cancer treatment reviews 2004;30(4):369-84.
2004: Jacek Jassem; Ewa Jassem; Joanna Jakóbkiewicz-Banecka; Witold Rzyman; Andrzej Badzio; Rafal Dziadziuszko; Grazyna Kobierska-Gulida; Amelia Szymanowska; Marcin Skrzypski; Maciej Zylicz
P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
Cancer 2004;100(9):1951-60.
2004: Elzbieta Senkus-Konefka; Tomasz Konefka; Jacek Jassem
The effects of tamoxifen on the female genital tract.
Cancer treatment reviews 2004;30(3):291-301.
2004: Barbara A Jereczek-Fossa; Jacek Jassem; Roberto Orecchia
Cervical lymph node metastases of squamous cell carcinoma from an unknown primary.
Cancer treatment reviews 2004;30(2):153-64.
2004: Dorota Dworakowska; Ewa Jassem; Jacek Jassem; Brigitte Peters; Rafal Dziadziuszko; Maciej Zylicz; Joanna Jakóbkiewicz-Banecka; Grazyna Kobierska-Gulida; Amelia Szymanowska; Jan Skokowski; Albert Roessner; Regine Schneider-Stock
MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC).
Lung cancer (Amsterdam, Netherlands) 2004;43(3):285-95.
2004: Leonard Reyno; Lesley Seymour; Dongsheng Tu; Susan Dent; Karen Gelmon; Barbara Walley; Anna Pluzanska; Vera Gorbunova; Avgust Garin; Jacek Jassem; Tadeusz Pienkowski; Janet Dancey; Laura Pearce; Mary MacNeil; Susan Marlin; David Lebwohl; Maurizio Voi; Kathleen Pritchard
Phase III study of N,N-diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine (BMS-217380-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(2):269-76.
2004: Dorota Dworakowska; Ewa Jassem; Jacek Jassem; Klaus Hermann Wiedorn; Carsten Boltze; Andrzej Karmoliński; Rafal Dworakowski; Jan Skokowski; Kazimierz Jaśkiewicz; Alexander Bosse; Eugenia Czestochowska
Prognostic relevance of altered pRb and p53 protein expression in surgically treated non-small cell lung cancer patients.
Oncology 2004;67(1):60-6.
2004: Elzbieta Senkus-Konefka; Jacek Jassem
Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16-20 March 2004.
Breast cancer research : BCR 2004;6(4):148-52.
2003: Jacek Jassem; P Kosmidis; Rodryg Ramlau; K Zarogoulidis; L Novakova; J Breton; P-L Etienne; C Seebacher; M Grivaux; A Ojala; D Aubert; F Lefresne
Oral vinorelbine in combination with cisplatin: a novel active regimen in advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(11):1634-9.
2003: Marzena Welnicka-Jaskiewicz; Jacek Jassem
The risks and benefits of hormonal replacement therapy in healthy women and in breast cancer survivors.
Cancer treatment reviews 2003;29(5):355-61.
2003: Witold Rzyman; Rafal Dziadziuszko; Jan Skokowski; Radoslaw Wilimski; Artur Raiter; Amelia Szymanowska; Jacek Jassem
The influence of blood transfusion on survival in operated non-small cell lung cancer patients.
The Journal of thoracic and cardiovascular surgery 2003;126(3):755-60.
2003: Barbara A Jereczek-Fossa; Andrzej Badzio; Jacek Jassem
Factors determining acute normal tissue reactions during postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;68(1):33-9.
2003: Jacek Jassem
Gemcitabine and anthracyclines in breast cancer.
Seminars in oncology 2003;30(2 Suppl 3):11-4.
2003: Marcin Skrzypski; Ewa Jassem; Jacek Jassem
[Alterations of locus P16INK4a/P14ARF in non-small cell lung cancer].
Pneumonologia i alergologia polska 2003;71(9-10):471-8.
2003: Elzbieta Senkus-Konefka; Liliana Krasińska; Joanna Pikiel; Wirginia Krasińska; Monika Nowaczyk; Jacek Jassem
[Efficacy and feasibility evaluation in long term pamidronate treatment of bone metastases].
Przegla̧d lekarski 2003;60(7):467-70.
2003: Krystyna Serkies; E Bednaruk-Mlynski; Rafal Dziadziuszko; Jacek Jassem
Conservative treatment for carcinoma of the anus--a report of 35 patients.
Neoplasma 2003;50(2):152-8.
2003: Jacek Jassem; Ewa Jassem
Modern management of symptoms and quality of life.
Current problems in cancer 2003;27(1):69-73.
2003: Jacek Jassem
Role of chemotherapy in the multimodality approach of non-small cell lung cancer.
Current problems in cancer 2003;27(1):64-8.
2002: Jacek Jassem
Combined chemotherapy and radiotherapy in inoperable non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2002;38 Suppl 3():S43-6.
2002: Jacek Jassem
Chemoradiotherapy of non-small cell lung cancer.
Expert review of anticancer therapy 2002;2(4):402-7.
2002: Jacek Jassem; Zsófia Schoket; Maciej Krzakowski
Cancer clinical trials in Central and Eastern Europe: historical review.
Critical reviews in oncology/hematology 2002;42(2):157-61.
2002: Krystyna Serkies; Barbara Wysocka; Janusz Emerich; Maria Hrabowska; Jacek Jassem
Salvage hemipelvis radiotherapy with fertility preservation in an adolescent with recurrent vulvar carcinoma.
Gynecologic oncology 2002;85(2):381-3.
2002: Barbara A Jereczek-Fossa; Jacek Jassem; Andrzej Badzio
Relationship between acute and late normal tissue injury after postoperative radiotherapy in endometrial cancer.
International journal of radiation oncology, biology, physics 2002;52(2):476-82.
2002: Marcin Skrzypski; Amelia Szymanowska; Anna Janowicz; Rafal Dziadziuszko; Rodryg Ramlau; Jerzy Kozielski; Anna Pilarska-Machowicz; Zuzanna Dobrzańska; Jacek Bigda; Maciej Krzakowski; Ewa Jassem; Jacek Jassem
[Serum anti-P53 antibodies (AB-anti-P53) in patients with advanced non-small cell lung cancer (NSCLC)].
Pneumonologia i alergologia polska 2002;70(7-8):353-8.
2002: K Matuszewska; Marcin Matuszewski; A Kowalczyk; Jacek Jassem
Penile metastases from urogenital primaries.
Neoplasma 2002;49(5):346-8.
2002: Ewa Jassem; Rodryg Ramlau; Rafal Dziadziuszko; Amelia Szymanowska; Joanna Jakóbkiewicz; Katarzyna Lamperska; Grazyna Kobierska; Jan Skokowski; Wojciech Dyszkiewicz; Andrzej mackiewicz; Maciej Zylicz; Jacek Jassem
[P53 and P16 gene mutations in non-small cell lung cancer].
Pneumonologia i alergologia polska 2002;70(1-2):64-70.
2002: Jacek Jassem; Maciej Krzakowski; Kazimierz Roszkowski; Rodryg Ramlau; Jan Marek Słomiński; Aleksandra Szczesna; Kazimierz Krawczyk; Barbara Mozejko-Pastewka; Joanna Lis; Krzysztof Miracki
A phase II study of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer: clinical outcomes and quality of life.
Lung cancer (Amsterdam, Netherlands) 2002;35(1):73-9.
2002: Dorota Dworakowska; Stanislaw Gózdz; Ewa Jassem; Andrzej Badzio; Grazyna Kobierska; A Urbaniak; Jan Skokowski; Iwona Damps; Jacek Jassem
Prognostic relevance of proliferating cell nuclear antigen and p53 expression in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2002;35(1):35-41.
2001: Alain Depierre; Gilles Freyer; Jacek Jassem; Hubert Orfeuvre; Rodryg Ramlau; E Lemarie; Piotr Koralewski; Louis Mauriac; Jean-Luc Breton; Thierry Delozier; Véronique Trillet-Lenoir
Oral vinorelbine: feasibility and safety profile.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(12):1677-81.
2001: Jacek Jassem
Combined modality treatment with chemotherapy and radiation in locally advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 2():S181-3.
2001: Jacek Jassem
Radiotherapy for non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 2():S177-80.
2001: Ewa Jassem; J Nikliński; R Rosell; W Niklińska; J Jakóbkiewicz; M Monzo; L Chyczewski; Grazyna Kobierska; Jan Skokowski; Maciej Zylicz; Jacek Jassem
Types and localisation of p53 gene mutations: a report on 332 non-small cell lung cancer patients.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 2():S47-51.
2001: Krystyna Serkies; Anna Kobierska; Krzysztof Konopa; T Sawicki; Jacek Jassem
The feasibility study on continuous 7-day-a-week external beam irradiation in locally advanced cervical cancer: a report on acute toxicity.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2001;61(2):197-202.
2001: Jacek Jassem; Rodryg Ramlau; H Karnicka-Młodkowska; Kazimierz Krawczyk; Maciej Krzakowski; Petr Zatloukal; E Lemarié; W Hartmann; L Novakova; M O'Brien; A Depierr
A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(10):1375-81.
2001: Jacek Jassem; T Pieńkowski; A Płuzańska; S Jelic; Vera Gorbunova; Z Mrsic-Krmpotic; J Berzins; T Nagykalnai; N Wigler; J Renard; S Munier; C Weil
Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1707-15.
2001: Krystyna Serkies; Andrzej Badzio; Barbara A Jereczek-Fossa; Z Tarnawska; Renata Nowak; P Szewczyk; Jacek Jassem
Rectal doses in intracavitary brachytherapy of gynecological malignancies: comparison of two dosimetric methods.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2001;58(1):37-41.
2001: Ewa Jassem; Jacek Bigda; Rafal Dziadziuszko; Beata Schlichtholz; D Le Roux; T Grodzki; Witold Rzyman; Krzysztof Konopa; M Poberezna; Z Dobrzańska; Jan Skokowski; thierry soussi; Jacek Jassem
Serum p53 antibodies in small cell lung cancer: the lack of prognostic relevance.
Lung cancer (Amsterdam, Netherlands) 2001;31(1):17-23.
2000: E Senkus; Tomasz Konefka; Monika Nowaczyk; Jacek Jassem
Second lower genital tract squamous cell carcinoma following cervical cancer. A clinical study of 46 patients.
Acta obstetricia et gynecologica Scandinavica 2000;79(9):765-70.
2000: Barbara A Jereczek-Fossa; Andrzej Badzio; Jacek Jassem
Recurrent endometrial cancer after surgery alone: results of salvage radiotherapy.
International journal of radiation oncology, biology, physics 2000;48(2):405-13.
2000: Jacek Jassem; Jan Skokowski; Rafal Dziadziuszko; Ewa Jassem; Amelia Szymanowska; Witold Rzyman; Andrzej Roszkiewicz
Results of surgical treatment of non-small cell lung cancer: validation of the new postoperative pathologic TNM classification.
The Journal of thoracic and cardiovascular surgery 2000;119(6):1141-6.
2000: Ewa Jassem; S Góźdź; Andrzej Badzio; Grazyna Kobierska; Jan Skokowski; Iwona Damps; A Urbaniak; Jacek Jassem
[Prognostic value of P53 protein in cells of non-small cell lung cancer].
Pneumonologia i alergologia polska 2000;68(7-8):327-35.
2000: Ewa Jassem; Iwona Damps; Jacek Jassem
[Genetic susceptibility to lung cancer].
Pneumonologia i alergologia polska 2000;68(3-4):161-8.
1999: Barbara Wysocka; Krystyna Serkies; Jaroslaw Debniak; Jacek Jassem; Janusz Limon
Sertoli cell tumor in androgen insensitivity syndrome--a case report.
Gynecologic oncology 1999;75(3):480-3.
1999: Jacek Jassem
Chemotherapy of advanced non-small cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10 Suppl 6():77-82.
1999: Krystyna Serkies; Barbara A Jereczek-Fossa; Andrzej Badzio; Jacek Jassem
Clodronate in the management of bone metastases: a clinical study of 91 patients.
Neoplasma 1999;46(5):317-22.
1999: Barbara Wysocka; M Wełnicka-Jaśkiewicz; K Matuszewska; P Słoniewski; Jacek Jassem; Ewa Izycka-Swieszewska; Jolanta Borowska-Lehman; Janusz Limon
The occurrence of cerebellar hemangioblastoma in numerous first degree relatives with von Hippel-Lindau disease.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 1999;37(3):175-8.
1998: Rafal Dziadziuszko; Ewa Jassem; Jacek Jassem
Clinical implications of molecular abnormalities in lung cancer.
Cancer treatment reviews 1998;24(5):317-30.
1998: Barbara A Jereczek-Fossa; Jacek Jassem; Renata Nowak; Andrzej Badzio
Late complications after postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases with application of linear-quadratic model.
International journal of radiation oncology, biology, physics 1998;41(2):329-38.
1998: Ewa Jassem; R Rosell; Jacek Jassem; M Monzo; Grazyna Kobierska; Andrzej Badzio; Andrzej Roszkiewicz; Jan Skokowski; A Szulc
[Evaluation of the prognostic significance of P53 mutation in patients with non-small cell lung cancer].
Pneumonologia i alergologia polska 1998;66(5-6):290-6.
1998: Barbara A Jereczek-Fossa; Jacek Jassem; H Karnicka-Młodkowska; Andrzej Badzio; R Moś-Antkowaik; Kazimierz Krawczyk; E Kowal; A Pilarska-Machowicz; E Radzikowska; K Malak
Does chemotherapy-induced leukopenia predict a response in small-cell lung cancer?
Journal of cancer research and clinical oncology 1998;124(2):106-12.
1997: Elzbieta Senkus-Konefka; Anna Kobierska; Jacek Jassem; Krystyna Serkies; Andrzej Badzio
Influence of brachytherapy applicators geometry on dose distribution in cervical cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1997;173(6):323-9.
1997: Elzbieta Senkus-Konefka; Anna Kobierska; Jacek Jassem; Andrzej Badzio
Patient-related factors determining geometry of intracavitary applicators and pelvic dose distribution during cervical cancer brachytherapy.
International journal of radiation oncology, biology, physics 1997;37(3):531-6.
1997: Ewa Jassem; Jacek Jassem
[New imaging methods in diagnosis of lung cancer].
Przegla̧d lekarski 1997;54(12):854-6.
1997: Ewa Jassem; Jacek Jassem; Jan Skokowski
[Bronchial carcinoid].
Pneumonologia i alergologia polska 1997;65(5-6):406-10.
1997: Ewa Jassem; nico van zandwijk; Jacek Jassem
[Radiation pneumonitis].
Pneumonologia i alergologia polska 1997;65(5-6):305-10.
1996: B Jereczek; Jacek Jassem; Anna Kobierska
Primary cancer of the fallopian tube. Report of 26 patients.
Acta obstetricia et gynecologica Scandinavica 1996;75(3):281-6.
1996: B Jereczek; Jacek Jassem; Anna Kobierska
Sarcoma of the uterus. A clinical study of 42 patients.
Archives of gynecology and obstetrics 1996;258(4):171-80.
1996: B Jereczek; Jacek Jassem; H Karnicka-Młodkowska; Andrzej Badzio; R Mos-Antkowiak; B Szczepek; E Chojak; Rafal Dziadziuszko; B Lisowska; K Malak
Autopsy findings in small cell lung cancer.
Neoplasma 1996;43(2):133-7.
1996: Ewa Jassem; Jacek Jassem
[Mutation of gene p53 in lung cancer].
Pneumonologia i alergologia polska 1996;64(1-2):5-10.
1995: Jacek Jassem; H Bartelink
Chemotherapy in locally advanced head and neck cancer: a critical reappraisal.
Cancer treatment reviews 1995;21(5):447-62.
1995: Ewa Jassem; Jacek Jassem
[The role of serum markers in diagnosis and treatment monitoring in patients with lung cancer].
Przegla̧d lekarski 1995;52(8):392-4.
1994: Jacek Jassem; H Karnicka-Młodkowska; Ewa Jassem; A Słupek; Jacek Zych; Elzbieta Wiatr; S Malak; R Moś-Antkowiak; L Szymaczek-Meyer; A Pilarska-Machowicz
Combination chemotherapy with cyclophosphamide, epirubicin and etoposide in small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1994;11(3-4):283-91.
1994: Ewa Jassem; Jacek Jassem
[Paraneoplastic syndromes in lung cancer].
Pneumonologia i alergologia polska 1994;62(9-10):540-4.
1993: Jacek Jassem; F Gyergyay; Sándor Kerpel-Fronius; T Nagykálnai; J Baumöhl; J Verweij; L Vuletic; Z Mechl; M Drozd-Lula; Svetislav Jelic
Combination of daily 4-h infusion of 5-fluorouracil and cisplatin in the treatment of advanced head and neck squamous-cell carcinoma: a South-East European Oncology Group study.
Cancer chemotherapy and pharmacology 1993;31(6):489-94.
1993: Jacek Jassem; H Karnicka-Młodkowska; C van Pottelsberghe; Martine Van Glabbeke; M A Noseda; Andrea Ardizzoni; F Gozzelino; A Planting; nico van zandwijk
Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients. EORTC Lung Cancer Cooperative Group.
European journal of cancer (Oxford, England : 1990) 1993;29A(12):1720-2.
1992: Ewa Jassem; Jacek Jassem
[Broncho-alveolar carcinoma--clinical picture and treatment methods].
Pneumonologia i alergologia polska 1992;60(3-4):65-8.
1992: Elisabeth Quoix; Giuseppe Giaccone; Jacek Jassem; H Karnicka; Elzbieta Wiatr; H Cortes-Funes; K J Roozendaal; A Kirkpatrick; D Evrard; nico van zandwijk
Epirubicin in previously untreated patients with small cell lung cancer: a phase II study by the EORTC Lung Cancer Cooperative Group.
European journal of cancer (Oxford, England : 1990) 1992;28A(10):1667-70.
1992: E Kánitz; K Kolaric; Jacek Jassem; Z Mechl; Marek Pawlicki; G Ringwald; J Rolski; Z Schoket; D Vukas; E Kaplan
Randomized phase II trial of high-dose 4'-epi-doxorubicin + cyclophosphamide versus high-dose 4'-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung cancer.
Oncology 1992;49(5):327-32.
1992: Jacek Jassem; H Karnicka-Młodkowska; M Drozd-Lula; A Strug; A Pilarska-Machowicz; A Michalski; E Kowal; R Moś-Antkowiak; Jacek Zych
Combination chemotherapy with vincristine, epirubicin and cyclophosphamide in small cell lung carcinoma. Polish Lung Cancer Cooperative Group.
European journal of cancer (Oxford, England : 1990) 1992;28(2-3):473-6.
1991: Ewa Jassem; Jacek Jassem
[Pleural mesothelioma--progress in diagnosis and treatment trials].
Pneumonologia i alergologia polska 1991;59(9-10):71-6.
1990: S Eckhardt; K Kolaric; D Vukas; E Kánitz; Z Schoket; Jacek Jassem; L Vuletic; Svetislav Jelic; Z Mechl; I Koza
Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG).
Medical oncology and tumor pharmacotherapy 1990;7(1):19-23.
1980: Jacek Jassem; Krystyna Serkies
Skin reactivity to dinitrochlorobenzene in cancer patients.
Neoplasma 1980;27(5):589-93.